Targeting cyclin-dependent kinase 2 CDK2: Insights from molecular docking and dynamics simulation&#160;- A systematic computational approach to discover novel cancer therapeutics.

seliciclib (CYC202) - Cyclacel, Cedars-Sinai

http://www.ncbi.nlm.nih.gov/pubmed/38964206

Ahmed Alfarhan; Anjana G V; Bharath Kumar Chagaleti; Jesu Arockiaraj; Kathiravan Muthu Kumaradoss; Rajakrishnan Rajagopal; S Karthick Raja Namasivayam; Shantha Kumar B

Jul 5, 2024